News & Updates

A recent study found an association between a healthy diet and greater physical fitness in middle-aged adults.

New drug applications approved by US FDA as of 16-30 June 2023 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Adults with hypertension, diabetes, and cardiovascular diseases may benefit from cutting back on coffee, especially the caffeinated variant, which has been shown to increase the burden of abdominal aortic calcification in a study.

For patients with cancer who have recurrent venous thromboembolism (VTE), direct oral anticoagulants (DOACs) compare favourably with low-molecular-weight heparin (LMWH) in terms of recurrence prevention, according to a study.

The use of bempedoic acid in primary prevention appears to lower the incidence of major cardiovascular events for high-risk patients, as shown in the subgroup analysis of the CLEAR Outcomes* trial.

Hypertensive individuals without a diagnosis of heart failure appear to have impaired ventilatory efficiency, which reflects an abnormal physiological response to exercise, according to a study.